Immunohistochemical expression of tumor necrosis factor α in neonatal leukomalacia

Pediatric Neurology

Volumn 14, Issue 1, 1996, Pages 13-16

  Deguchi, Kimiko ^a   Mizuguchi, Masashi ^a   Takashima, Sachio ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRAIN DEVELOPMENT; CLINICAL ARTICLE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOMALACIA; NEWBORN; NEWBORN DISEASE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0030028071     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/0887-8994(95)00223-5     Document Type: Article

References (20)

1. Calvert SA, Hoskins EM, Forsyth SC. Periventricular leukomalacia. Ultrasonic and neurological outcome. Acta Pediatr Scand 1986;75: 486-96.
2. Armstrong D, Norman MB. Periventricular leukomalacia in neonates. Arch Dis Child 1974;49:367-75.
3. Chung IY, Benenste EN. Tumor necrosis factor-a production by astrocytes: Induction by lipopolysaccharide, interferon-γ and interleukin-1β. J Immunol 1990;144:2999-3007.
4. McCracken GH Jr, Mustafa MM, Ramilo O, Olsen KC. Cerebral fluid interleukin 1-beta and tumor necrosis factor concentrations and outcome from neonatal gram-negative enteric bacillary meningitis. Pediatr Infect Dis J 1989;8:155-9.
5. Caplan MS, Sun XM, Hueh W, Hagerman JR. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 1990;116:960-4.
6. De Bont ESZM, Mantens A, van Raan J, et al. Diagnostic value of plasma levels of tumor necrosis factor a (TNFα) and interleukin-6 (IL-6) in newborn with sepsis. Acta Pediatr 1994;83:694-9.
7. Iida K, Takashima S, Takeuti Y. Etiology and distribution of neonatal leukomalacia. Pediatr Neurol 1992;8:205-9.
8. Takashima S, Becker LE. Developmental changes of glial fibrillary acidic protein in cerebral white matter. Arch Neurol 1983;40:14-8.
9. Iida K, Takashima S, Takeuchi Y, Ohno T, Ueda K. Neuropathologic study of newborns with perinatal-onset leukomalacia. Pediatr Neurol 1993;9:45-8.
10. Takashima S, Tanaka K. Development of cerebrovascular architecture: Its relationship to periventricular leukomalacia. Arch Neurol 1978;35:11-6.
11. Yoshioka H, Goma H, Nioka S, et al. Bilateral carotid artery occlusion causes periventricular leukomalacia in neonatal dogs. Dev Brain Res 1994;78:273-8.
12. Oka A, Belliveau J, Rosenberg PA, Volpe JJ. Vulnerability of oligodendroglia to glutamate. J Neurosci 1993;13:1441-53.
13. Merril JE. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: Normal and pathological. Dev Neurosci 1992;14:1-10.
14. Leiberman AP, Pitha PM, Shin HS, Shin ML. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neutropic virus. Proc Natl Acad Sci 1989;86: 6348-52.
15. Merril JE, Koyanagi Y, Zack J, Thormas L, Martin F, Chen ISY. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immuno-deficiency virus type I. J Virol 1992;66: 2217-25.
16. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW. Cytokine production by human fetal microglia and astrocytes. J Immunol 1993;150:2659-67.
17. Tracy KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470-3.
18. Selmaj K, Raine CS, Path FRC, Cross AH. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1986;2:339-46.
19. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol 1990;144:129-35.
20. Leviton A. Preterm birth and cerebral palsy: Is tumor necrosis factor the missing link? Dev Med Child Neurol 1993;35:549-58.